Abstract: A percutaneous absorption promoting agent comprising (A) at least one anionic surfactant and one or two or more of surfactants having a nitrogen atom in the molecule other than anionic surfactants, (B) one or two or more of anionic surfactants and one or two or more of nonionic surfactants not having a nitrogen atom in the molecule, (C) one or two or more of surfactants selected from the group consisting of amphoteric surfactant and semi-polar surfactants and at least one nonionic surfactant having a nitrogen atom in the molecule, (D) one or two or more of surfactants selected from the group consisting of nonionic surfactants, amphoteric surfactants, semi-polar surfactants and cationic surfactants having a nitrogen atom in the molecule, and one or two or more of nonionic surfactants not having a nitrogen atom in the molecule, or (E) an amine oxide as the active ingredient, and a dermatological preparation containing these percutaneous absorption promoting agent and drug components.

Abstract: A shampoo composition containing components (I) to (V) shown below:(I) at least one alkyloylalkyltaurine salt type anionic surfactant of the formula (A): ##STR1## wherein R.sub.1 represents an alkyl group, an alkenyl group or a hydroxyalkyl group with an average carbon number of 7 to 19, R.sub.2 is a lower alkyl group with an average carbon number of 1 to 3, and M an alkali metal or an organic amine;(II) at least one betaine type amphoteric surfactant;(III) at least one nonionic surfactant with an HLB of 10 to 16;(IV) at least one surfactant selected from alkylolamide type nonionic surfactants represented by the formula (B): ##STR2## wherein R.sub.3 represents an alkyl group or an alkenyl group with an average carbon atom of 7 to 19, m and n are integers, and m+n is 1 to 5, and semi-polar surfactants;(V) at least one cationic high molecular weight compound.

Abstract: A percutaneous absorption promoting agent comprising (A) at least one anionic surfactant and one or two or more of surfactants having a nitrogen atom in the molecule other than anionic surfactants, (B) one or two or more of anionic surfactants and one or two or more of nonionic surfactants not having a nitrogen atom in the molecule, (C) one or two or more of surfactants selected from the group consisting of amphoteric surfactant and semi-polar surfactants and at least one nonionic surfactant having a nitrogen atom in the molecule, (D) one or two or more of surfactants selected from the group consisting of nonionic surfactants, amphoteric surfactants, semi-polar surfactants and cationic surfactants having a nitrogen atom in the molecule, and one or two or more of nonionic surfactants not having a nitrogen atom in the molecule, or (E) an amine oxide as the active ingredient, and a dermatological preparation containing these percutaneous absorption promoting agent and drug components.

Abstract: Cutaneous administration of ubidecarenone, for example, application of ubidecarenone in the form of an ointment has been proven to be effective for treatment of various skin disorders caused by radiation, such as radiation ulcers and radiation dermatitis.